BRPI0508936A - composições e métodos para redução ou prevenção de obesidade - Google Patents

composições e métodos para redução ou prevenção de obesidade

Info

Publication number
BRPI0508936A
BRPI0508936A BRPI0508936-0A BRPI0508936A BRPI0508936A BR PI0508936 A BRPI0508936 A BR PI0508936A BR PI0508936 A BRPI0508936 A BR PI0508936A BR PI0508936 A BRPI0508936 A BR PI0508936A
Authority
BR
Brazil
Prior art keywords
compositions
methods
reducing
isoflavones
carnitine
Prior art date
Application number
BRPI0508936-0A
Other languages
English (en)
Inventor
Yuanlong Pan
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0508936A publication Critical patent/BRPI0508936A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

COMPOSIçõES E MéTODOS PARA REDUçãO OU PREVENçãO DE OBESIDADE. A presente invenção refere-se a composições úteis para o controle de peso em um animal. As composições compreendem uma ou mais isoflavonas ou metabolitos de isoflavona e, em algumas modalidades, incluem ácido linoléico conjugado e/ou L-carnitina. A invenção refere-se também a métodos úteis para o controle de peso em um animal utilizando composições que compreendem uma ou mais isoflavonas, ácido linoléico conjugado e/ou L-carnitina. Preferivelmente, as composições e os métodos empregam uma combinação de uma ou mais isoflavonas, ou uma combinação de uma ou mais isoflavonas em conjunto com ácido linoléico conjugado e L-carnitina.
BRPI0508936-0A 2004-03-17 2005-03-17 composições e métodos para redução ou prevenção de obesidade BRPI0508936A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55387104P 2004-03-17 2004-03-17
PCT/EP2005/002865 WO2005089567A1 (en) 2004-03-17 2005-03-17 Compositions and methods for reducing or preventing obesity

Publications (1)

Publication Number Publication Date
BRPI0508936A true BRPI0508936A (pt) 2007-09-25

Family

ID=34972657

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508936-0A BRPI0508936A (pt) 2004-03-17 2005-03-17 composições e métodos para redução ou prevenção de obesidade

Country Status (12)

Country Link
US (2) US8193240B2 (pt)
EP (2) EP1750523B1 (pt)
JP (2) JP5283902B2 (pt)
CN (1) CN1933739A (pt)
AU (1) AU2005224017B2 (pt)
BR (1) BRPI0508936A (pt)
CA (1) CA2559974C (pt)
DE (1) DE602005022431D1 (pt)
ES (2) ES2559777T3 (pt)
RU (1) RU2366274C2 (pt)
WO (1) WO2005089567A1 (pt)
ZA (1) ZA200608626B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1933739A (zh) * 2004-03-17 2007-03-21 雀巢技术公司 减少或预防肥胖的组合物和方法
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
CN101287460B (zh) * 2005-08-17 2012-04-25 希尔氏宠物营养品公司 预防和治疗肾病的组合物
US8226973B2 (en) * 2005-11-02 2012-07-24 Nestec, S. A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
BRPI0708361A2 (pt) * 2006-02-28 2011-05-24 Nestec S.A composições e métodos para a indução de crescimento ósseo e para a inibição de perda óssea
EP1875908A1 (de) * 2006-07-05 2008-01-09 Johannes Huber Verwendung von Chrysin
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
WO2008016768A1 (en) * 2006-08-02 2008-02-07 Roberta Diaz Brinton Phytoestrogenic formulations and uses thereof
US8680140B2 (en) 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
JP5355395B2 (ja) * 2007-06-13 2013-11-27 大塚製薬株式会社 エクオール含有抽出物及びその製造方法、エクオール抽出方法、並びにエクオールを含む食品
CN101326966B (zh) * 2008-07-22 2010-09-08 浙江大学 一种改进大黄鱼品质的饲料添加剂
US8835490B2 (en) * 2008-08-15 2014-09-16 Nestec Sa Methods for enhancing energy metabolism
JP2012513764A (ja) * 2008-12-30 2012-06-21 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルにおいて体重に関連する障害を処置および予防するための組成物および方法
AU2009335094B2 (en) 2008-12-30 2012-11-15 Hill's Pet Nutrition, Inc. Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
WO2010100653A2 (en) * 2009-02-02 2010-09-10 Laila Nutraceuticals Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
JP5470648B2 (ja) * 2009-03-02 2014-04-16 学校法人加計学園 ペルオキシゾーム増殖剤応答性受容体β／δ活性化剤
KR101119877B1 (ko) 2009-03-03 2012-02-28 (주)에이치케이바이오텍 지방감소를 위한 피부도포용 조성물 및 이것의 제조방법
AU2010303872B2 (en) * 2009-10-09 2016-06-23 Société des Produits Nestlé S.A. Methods for preventing or treating sarcopenia and muscle atrophy in animals
JP5661801B2 (ja) * 2010-01-06 2015-01-28 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物において体重状態を管理する方法
WO2012087486A1 (en) * 2010-12-20 2012-06-28 Hill's Pet Nutrition, Inc. Pet food compositions for inducing a satiety response
EP2654777A4 (en) * 2010-12-21 2014-07-09 Nestec Sa METHOD AND COMPOSITIONS FOR ADMINISTERING THE BLOOD SUGAR IN ANIMALS
EP2898923A3 (en) * 2011-04-15 2015-10-07 Nestec S.A. Isoflavones for regulating sirtuin gene expression
EP2699095A4 (en) * 2011-04-20 2015-04-15 Nestec Sa METHODS AND COMPOSITIONS THAT CAN BE USED TO PREVENT AND TREAT HYPERLEPTINEMIA
DK3164125T3 (da) * 2014-07-03 2023-12-18 Silti Ag Fremgangsmåder og sammensætninger til behandling af overvægt, forhindring af vægtforøgelse, fremme vægttab, fremme slankning eller behandling eller forebyggelse af udvikling af diabetes
EP3223634A1 (en) * 2014-11-25 2017-10-04 Nestec S.A. Methods and compositions for preserving lean body mass and promoting fat loss during weight loss
JP7206113B2 (ja) * 2016-12-15 2023-01-17 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 小型イヌ科動物用の組成物及び方法
US10842809B2 (en) * 2016-12-16 2020-11-24 Hills Pet Nutrition, Inc. Pet food compositions
CN106804483B (zh) * 2016-12-30 2020-11-10 浙江海洋大学 一种提高大黄鱼体石榴酸的方法
CN108260731A (zh) * 2017-01-03 2018-07-10 江苏益力达生物科技有限公司 一种控制宠物犬猫体重的营养膏
CN106901042A (zh) * 2017-04-27 2017-06-30 上海美嘉饲料有限公司 一种提高种公猪精子活力的饲料添加剂
CN108354080A (zh) * 2018-05-14 2018-08-03 江苏奈乐宠物食品科技有限公司 一种肥胖期专用减肥犬粮的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
CA2117537A1 (en) 1992-12-25 1994-07-07 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Granular colorant and formula feed containing the same
US5962043A (en) * 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
SE506191C2 (sv) 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
JPH10175866A (ja) 1996-12-18 1998-06-30 Showa Denko Kk 動物用ストレス反応緩和剤及びストレス反応の緩和方法
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6204291B1 (en) * 1998-06-26 2001-03-20 The Iams Company Process for promoting weight loss in overweight dogs
US20010041187A1 (en) * 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
MXPA01008598A (es) * 1999-02-24 2003-06-24 Szabo Joseph Composiciones y metodos dieteticos.
GB2355382A (en) * 1999-08-24 2001-04-25 Gilbertson & Page Ltd Conjugated linoleic acid for weight reduction in a dog
ITMI991894A1 (it) 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
US20020010141A1 (en) * 2000-03-31 2002-01-24 Jonathan Ingram Isoflavones for treatment of obesity
KR20020060577A (ko) * 2000-07-07 2002-07-18 아키라 이가키 비만 억제제
JP2002080351A (ja) 2000-09-07 2002-03-19 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤
AR035212A1 (es) * 2000-11-09 2004-05-05 Cargill Inc Metodos y disposiciones de elaboracion para el procesamiento de porotos de soja, para producir aceite de soja, concentrados de germen de soja y harinas de soja, y procesos de produccion en linea para separar una corriente de porotos de soja partidos
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
GB0119052D0 (en) 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
US20030138547A1 (en) * 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
WO2003068218A1 (en) * 2002-02-15 2003-08-21 N.V. Nutricia Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
JP2003286180A (ja) * 2002-03-28 2003-10-07 Fuji Oil Co Ltd 肥満抑制剤及びそれを含む食品
EP1388297A1 (en) * 2002-08-06 2004-02-11 Nestec S.A. Calcium absorption enhancer
US20040151761A1 (en) 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
JP4152818B2 (ja) * 2003-02-06 2008-09-17 日清オイリオグループ株式会社 共役脂肪酸を有効成分とする高血圧予防剤およびその用途
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
WO2005058064A1 (ja) 2003-12-19 2005-06-30 Menicon Co., Ltd. アスタキサンチン配合ペット用食物
CN1933739A (zh) * 2004-03-17 2007-03-21 雀巢技术公司 减少或预防肥胖的组合物和方法
BRPI0708361A2 (pt) * 2006-02-28 2011-05-24 Nestec S.A composições e métodos para a indução de crescimento ósseo e para a inibição de perda óssea

Also Published As

Publication number Publication date
EP2208422A1 (en) 2010-07-21
CN1933739A (zh) 2007-03-21
DE602005022431D1 (de) 2010-09-02
ZA200608626B (en) 2008-07-30
ES2346234T3 (es) 2010-10-13
EP1750523B1 (en) 2010-07-21
CA2559974A1 (en) 2005-09-29
AU2005224017A1 (en) 2005-09-29
CA2559974C (en) 2012-08-14
US20050222050A1 (en) 2005-10-06
RU2006136420A (ru) 2008-04-27
ES2559777T3 (es) 2016-02-15
EP2208422B1 (en) 2015-11-25
JP5283902B2 (ja) 2013-09-04
JP2007529211A (ja) 2007-10-25
EP1750523A1 (en) 2007-02-14
WO2005089567A1 (en) 2005-09-29
JP2012165746A (ja) 2012-09-06
AU2005224017B2 (en) 2010-12-16
US8883192B2 (en) 2014-11-11
US8193240B2 (en) 2012-06-05
RU2366274C2 (ru) 2009-09-10
US20120270814A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
BRPI0508936A (pt) composições e métodos para redução ou prevenção de obesidade
BRPI0519265A2 (pt) composiÇÕes incluindo ferro
BRPI0713349A2 (pt) Inibidores de proteína tirosina fosfatase humana e métodos de utilização
BR112012017564A2 (pt) Formulação antimicrobiana
BR112012006692A2 (pt) composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas
BRPI0918611B8 (pt) composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
BR112012008145A2 (pt) método e sistema de fornecer preferências de controle para usuário de internet
BRPI0713357A2 (pt) Inibidores de proteína tirosina fosfatase humana e método de utilização.
BRPI0518953A2 (pt) composiÇÕes e mÉtodos de seu uso para melhorar a condiÇço e a aparÊncia da pele
BRPI0408373A (pt) composições para tratamento de pele que aumentam e reparam a função de barreira da pele
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
BRPI0701267A (pt) verniz
BRPI0810130A8 (pt) Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida
BRPI0418330A (pt) composições sólidas de drogas de solubilidade baixa e poloxámeros
BR112013010388A2 (pt) "composição herbicida sinérgica, que contém fluroxipir e quinclorac".
BRPI0702163A (pt) composições de toner e métodos
BRPI0600199A (pt) usos de ácido pinolênico ou um seu derivado e de uma composição
BRPI0514295A (pt) 1, 5-difenilpirazóis
BRPI0515582A (pt) 3-(2-hidroxifenil)pirazóis e seu uso como moduladores de hsp90
BR112013011882A2 (pt) fórmula nutricional adaptada à idade com densidade calórica particularmente adaptada para bebês e crianças
BRPI0508489A (pt) efeitos de instabilidade de controle
BRPI0717458A8 (pt) Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional
BR112015003680A2 (pt) métodos para controle de perda de peso e massa corpórea
BR112022004766A2 (pt) Composição alimentícia na forma de uma emulsão óleo-em-água, processo para fabricar uma composição e uso de proteína de planta
BR112022006999A2 (pt) Composição contendo a2-beta-caseína para promover um temperamento melhor em mamíferos jovens

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 36/48 , A61K 31/201 , A61K 31/205 , A61P 3/04 , A23L 1/30 , A23L 1/29

Ipc: A61K 36/48 (2006.01), A61K 31/205 (2006.01), A61K

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B15G Petition not considered as such [chapter 15.7 patent gazette]